These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21591864)

  • 1. Epithelial membrane protein-2 (EMP2) and experimental proliferative vitreoretinopathy (PVR).
    Telander DG; Morales SA; Mareninov S; Forward K; Gordon LK
    Curr Eye Res; 2011 Jun; 36(6):546-52. PubMed ID: 21591864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
    Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAK activation and the role of epithelial membrane protein 2 (EMP2) in collagen gel contraction.
    Morales SA; Mareninov S; Wadehra M; Zhang L; Goodglick L; Braun J; Gordon LK
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):462-9. PubMed ID: 18469192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells.
    Morales SA; Telander DG; Mareninov S; Nagy A; Wadehra M; Braun J; Gordon LK
    Exp Eye Res; 2012 Sep; 102():10-6. PubMed ID: 22728127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rewiring integrin-mediated signaling and cellular response with the peripheral myelin protein 22 and epithelial membrane protein 2 components of the tetraspan web.
    Morales SA; Telander D; Notterpek L; Wadehra M; Braun J; Gordon LK
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5465-72. PubMed ID: 21421883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen gel contraction by ARPE-19 cells is mediated by a FAK-Src dependent pathway.
    Morales SA; Mareninov S; Prasad P; Wadehra M; Braun J; Gordon LK
    Exp Eye Res; 2007 Dec; 85(6):790-8. PubMed ID: 17915217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy.
    Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC
    Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.
    Wang Y; Yuan Z; You C; Han J; Li H; Zhang Z; Yan H
    BMC Ophthalmol; 2014 Nov; 14():144. PubMed ID: 25421815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy.
    Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2).
    Morales SA; Mareninov S; Coulam P; Wadehra M; Goodglick L; Braun J; Gordon LK
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4949-56. PubMed ID: 19494199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
    Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
    Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
    Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells.
    Wong CA; Potter MJ; Cui JZ; Chang TS; Ma P; Maberley AL; Ross WH; White VA; Samad A; Jia W; Hornan D; Matsubara JA
    Can J Ophthalmol; 2002 Jun; 37(4):211-20. PubMed ID: 12095094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Curcumin on Epidermal Growth Factor in Proliferative Vitreoretinopathy.
    Ren YX; Ma JX; Zhao F; An JB; Geng YX; Liu LY
    Cell Physiol Biochem; 2018; 47(5):2136-2146. PubMed ID: 29975931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
    Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
    FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR.
    Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM
    Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yes-associated protein is essential for proliferative vitreoretinopathy development via the epithelial-mesenchymal transition in retinal pigment epithelial fibrosis.
    Zhang W; Li J
    J Cell Mol Med; 2021 Nov; 25(21):10213-10223. PubMed ID: 34598306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting matrix stiffness-induced activation of retinal pigment epithelial cells through the RhoA/YAP pathway ameliorates proliferative vitreoretinopathy.
    Zhang W; Han H
    Exp Eye Res; 2021 Aug; 209():108677. PubMed ID: 34147507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edible mushroom (Agaricus bisporus) lectin modulates human retinal pigment epithelial cell behaviour in vitro.
    Kent D; Sheridan C; Tomkinson HA; White S; Hiscott P; Grierson I
    Exp Eye Res; 2003 Feb; 76(2):213-9. PubMed ID: 12565809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model.
    Daftarian N; Baigy O; Suri F; Kanavi MR; Balagholi S; Afsar Aski S; Moghaddasi A; Nourinia R; Abtahi SH; Ahmadieh H
    Exp Eye Res; 2021 Jul; 208():108622. PubMed ID: 34022176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.